BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 9716134)

  • 1. A dual thrombin receptor system for platelet activation.
    Kahn ML; Zheng YW; Huang W; Bigornia V; Zeng D; Moff S; Farese RV; Tam C; Coughlin SR
    Nature; 1998 Aug; 394(6694):690-4. PubMed ID: 9716134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAR3 is a cofactor for PAR4 activation by thrombin.
    Nakanishi-Matsui M; Zheng YW; Sulciner DJ; Weiss EJ; Ludeman MJ; Coughlin SR
    Nature; 2000 Apr; 404(6778):609-13. PubMed ID: 10766244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil proteases can inactivate human PAR3 and abolish the co-receptor function of PAR3 on murine platelets.
    Cumashi A; Ansuini H; Celli N; De Blasi A; O'Brien PJ; Brass LF; Molino M
    Thromb Haemost; 2001 Mar; 85(3):533-8. PubMed ID: 11307827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of protease activated receptor 3 (PAR3) is upregulated by induction of megakaryocyte phenotype in human erythroleukemia (HEL) cells.
    Cupit LD; Schmidt VA; Gnatenko DV; Bahou WF
    Exp Hematol; 2004 Oct; 32(10):991-9. PubMed ID: 15504554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protease-activated receptor 3 is a second thrombin receptor in humans.
    Ishihara H; Connolly AJ; Zeng D; Kahn ML; Zheng YW; Timmons C; Tram T; Coughlin SR
    Nature; 1997 Apr; 386(6624):502-6. PubMed ID: 9087410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of thrombin signalling in platelets in haemostasis and thrombosis.
    Sambrano GR; Weiss EJ; Zheng YW; Huang W; Coughlin SR
    Nature; 2001 Sep; 413(6851):74-8. PubMed ID: 11544528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin.
    Kahn ML; Nakanishi-Matsui M; Shapiro MJ; Ishihara H; Coughlin SR
    J Clin Invest; 1999 Mar; 103(6):879-87. PubMed ID: 10079109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteinase-activated receptors (PARs)--the PAR3 Neo-N-terminal peptide TFRGAP interacts with PAR1.
    Kaufmann R; Schulze B; Krause G; Mayr LM; Settmacher U; Henklein P
    Regul Pept; 2005 Feb; 125(1-3):61-6. PubMed ID: 15582715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development.
    Vretenbrant K; Ramström S; Bjerke M; Lindahl TL
    Thromb Haemost; 2007 Mar; 97(3):417-24. PubMed ID: 17334509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Par4 is required for platelet thrombus propagation but not fibrin generation in a mouse model of thrombosis.
    Vandendries ER; Hamilton JR; Coughlin SR; Furie B; Furie BC
    Proc Natl Acad Sci U S A; 2007 Jan; 104(1):288-92. PubMed ID: 17190826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
    Bilodeau ML; Hamm HE
    J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pepducin-based intervention of thrombin-receptor signaling and systemic platelet activation.
    Covic L; Misra M; Badar J; Singh C; Kuliopulos A
    Nat Med; 2002 Oct; 8(10):1161-5. PubMed ID: 12357249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for thrombin receptor signaling in endothelial cells during embryonic development.
    Griffin CT; Srinivasan Y; Zheng YW; Huang W; Coughlin SR
    Science; 2001 Aug; 293(5535):1666-70. PubMed ID: 11533492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of plasmin-induced protease-activated receptor 4 activation in platelets.
    Mao Y; Jin J; Daniel JL; Kunapuli SP
    Platelets; 2009 May; 20(3):191-8. PubMed ID: 19437337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protease-activated receptors in cardiovascular diseases.
    Leger AJ; Covic L; Kuliopulos A
    Circulation; 2006 Sep; 114(10):1070-7. PubMed ID: 16952995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the thrombin receptor in development and evidence for a second receptor.
    Connolly AJ; Ishihara H; Kahn ML; Farese RV; Coughlin SR
    Nature; 1996 Jun; 381(6582):516-9. PubMed ID: 8632823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against thrombosis in mice lacking PAR3.
    Weiss EJ; Hamilton JR; Lease KE; Coughlin SR
    Blood; 2002 Nov; 100(9):3240-4. PubMed ID: 12384423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease-activated receptor-1 can mediate responses to SFLLRN in thrombin-desensitized cells: evidence for a novel mechanism for preventing or terminating signaling by PAR1's tethered ligand.
    Hammes SR; Coughlin SR
    Biochemistry; 1999 Feb; 38(8):2486-93. PubMed ID: 10029543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protease-activated receptors and platelet function.
    Coughlin SR
    Thromb Haemost; 1999 Aug; 82(2):353-6. PubMed ID: 10605724
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation.
    Wu CC; Teng CM
    Eur J Pharmacol; 2006 Sep; 546(1-3):142-7. PubMed ID: 16890935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.